FDA panel says no to Alkermes depression pill
An advisory panel to the U.S. FDA voted against approving Alkermes ’ treatment for depression in patients with an inadequate response to standard antidepressant therapies.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news
More News: Depression | Pharmaceuticals